Retinal Disease Product Applications In North America

2 applications found

In North America Available In North America Near North America

Sustained-Release Drug Delivery Platforms for Retinal Diseases

Glaukos is developing multiple micro-invasive, bioerodible, sustained-release drug delivery platforms designed to be used in the treatment of various retinal disease, including age-related macular degeneration (AMD) and diabetic macular ...

ByGlaukos Corporation based in San Clemente, CALIFORNIA (USA)

Retinal Vein Occlusion (RVO)

RVO is a chronic condition of the eye in which small blood clots form in the small veins that carry blood away from the retina. When this occurs, there is hemorrhage of blood from the blocked vessels into the surrounding retinal tissue leading to swelling (macular edema) and formation of new blood vessels (neovascularization). Left untreated, RVO typically leads to progressive deterioration of vision leading to permanent blindness. Risk factors for RVO include atherosclerosis, diabetes and high blood pressure. ...

ByCerevast Medical, Inc. based in Bothell, WASHINGTON (USA)

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you